一品红(300723.SZ)子公司获得丙戊酸钠注射用浓溶液注册证书

Core Viewpoint - The company Yipinhong (300723.SZ) has received a drug registration certificate for sodium valproate injection solution from the National Medical Products Administration, enabling it to sell this product in the domestic market [1] Group 1 - The approval of the sodium valproate injection solution registration certificate enhances the company's product pipeline and variety [1] - This development strengthens the company's competitiveness in the chronic disease medication sector [1]